Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126486 · ClinicalTrials.gov registry record · Phase 4
A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke
A Phase 4 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 4
- Development phase
- 11,931
- Enrollment target
NCT04126486: Completed Phase 4 study, sponsored by Bristol-Myers Squibb.
NCT04126486 is a Phase 4 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 11,931 participants, above the 517-participant average among 9,235 other Phase 4 trials with a reported enrollment target (2208% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04126486, a Phase 4 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 11,931 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if an AF detection intervention in men and women at least 70 years of age with undiagnosed atrial fibrillation (AF) or atrial flutter (AFL) reduces the person-years incidence rate of stroke compared to usual care (no AF detection intervention).
Interventions
- OTHER Zio®XT Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,931 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2023-06-30 |
| Phase | Phase 4 |
What the finished NCT04126486 record still lists
NCT04126486 is an interventional study that assigns participants to a tested intervention. Its 11,931 participants enrollment target places it among the larger protocols in the corpus, above the 517-participant average among 9,235 other Phase 4 trials with a reported enrollment target (2208% higher).
The record links to 0 conditions, and to 1 intervention - of which Zio®XT Monitor is the first listed.
NCT04126486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04126486 about?
NCT04126486 is a clinical study titled "A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke". The purpose of this study is to determine if an AF detection intervention in men and women at least 70 years of age with undiagnosed atrial fibrillation (AF) or atrial flutter (AFL) reduces the person-years incidence rate of stroke compared to usual care (no AF detection intervention).
What is the current status of trial NCT04126486?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 11,931 participants. The study started on 2019-12-17. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04126486?
The interventions under investigation include: Zio®XT Monitor (OTHER).
Who is sponsoring clinical trial NCT04126486?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04126486's enrollment target sits among peer trials
11,931 7th of 2000 higher than 1,994 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI